![]() |
Name |
(4alpha,5beta,6alpha,7alpha,10alpha)-1-Aromadendrene
|
Molecular Formula | C15H24 | |
IUPAC Name* |
1,1,4,7-tetramethyl-1a,2,3,4,6,7,7a,7b-octahydrocyclopropa[e]azulene
|
|
SMILES |
CC1CCC2C(C2(C)C)C3C1=CCC3C
|
|
InChI |
InChI=1S/C15H24/c1-9-6-8-12-14(15(12,3)4)13-10(2)5-7-11(9)13/h7,9-10,12-14H,5-6,8H2,1-4H3
|
|
InChIKey |
KDDAGEWDPAMROQ-UHFFFAOYSA-N
|
|
Synonyms |
(4alpha,5beta,6alpha,7alpha,10alpha)-1-Aromadendrene; 1-Aromadendrene; 3,3,7,11-tetramethyl-tricyclo[6.3.0.0(2,4)]undec-8-ene; 1,1,4,7-Tetramethyl-1a,2,3,4,6,7,7a,7b-octahydro-1H-cyclopropa[e]azulene; 1,1,4,7-tetramethyl-1H,1aH,2H,3H,4H,6H,7H,7aH,7bH-cyclopropa[e]azulene; 1H-Cycloprop[e]azulene, 1a,2,3,4,6,7,7a,7b-octahydro-1,1,4,7-tetramethyl-; [1aR-(1aalpha,4alpha,7alpha,7abeta,7balpha)]-1a,2,3,4,6,7,7a,7b-Octahydro-1,1,4,7-tetramethyl-1H-cycloprop[e]azulene
|
|
CAS | 111821-79-5 | |
PubChem CID | 579031 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 204.35 | ALogp: | 4.4 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 15 | QED Weighted: | 0.496 |
Caco-2 Permeability: | -4.413 | MDCK Permeability: | 0.00001120 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.324 |
30% Bioavailability (F30%): | 0.683 |
Blood-Brain-Barrier Penetration (BBB): | 0.739 | Plasma Protein Binding (PPB): | 97.07% |
Volume Distribution (VD): | 4.262 | Fu: | 2.99% |
CYP1A2-inhibitor: | 0.444 | CYP1A2-substrate: | 0.665 |
CYP2C19-inhibitor: | 0.253 | CYP2C19-substrate: | 0.915 |
CYP2C9-inhibitor: | 0.434 | CYP2C9-substrate: | 0.52 |
CYP2D6-inhibitor: | 0.073 | CYP2D6-substrate: | 0.602 |
CYP3A4-inhibitor: | 0.608 | CYP3A4-substrate: | 0.473 |
Clearance (CL): | 14.374 | Half-life (T1/2): | 0.03 |
hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.146 |
Drug-inuced Liver Injury (DILI): | 0.193 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.579 | Maximum Recommended Daily Dose: | 0.59 |
Skin Sensitization: | 0.031 | Carcinogencity: | 0.128 |
Eye Corrosion: | 0.096 | Eye Irritation: | 0.265 |
Respiratory Toxicity: | 0.859 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002222 | ![]() |
0.424 | D04SFH | ![]() |
0.282 | ||
ENC003084 | ![]() |
0.414 | D0S3WH | ![]() |
0.276 | ||
ENC001408 | ![]() |
0.400 | D0B4RU | ![]() |
0.265 | ||
ENC001192 | ![]() |
0.393 | D0N6FH | ![]() |
0.260 | ||
ENC003074 | ![]() |
0.377 | D0Y5ZA | ![]() |
0.256 | ||
ENC001196 | ![]() |
0.371 | D09NNA | ![]() |
0.242 | ||
ENC002340 | ![]() |
0.367 | D0I2SD | ![]() |
0.239 | ||
ENC000787 | ![]() |
0.344 | D0V8HA | ![]() |
0.237 | ||
ENC001834 | ![]() |
0.344 | D0K0EK | ![]() |
0.235 | ||
ENC001183 | ![]() |
0.344 | D0Y7LD | ![]() |
0.228 |